CompletedPhase 4

Persistence of Antibody Response to N. Meningitidis Group C in Children

Poland, Spain489 participantsStarted 2005-02

Plain-language summary

Persistence of Antibody Response to N. meningitidis Group C in Children

Who can participate

Age range7 Months

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * healthy children Exclusion Criteria: * previous ascertained or suspected disease caused by N. meningitidis * previous significant acute or chronic infections * any other serious disease

What they're measuring

Immunogenicity: serum antibody responses, as measured by bactericidal activity,using hBCA

Trial details

NCT IDNCT00316654

SponsorNovartis Vaccines

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2005-10

View on ClinicalTrials.gov More Prevention of Meningococcal Infection trials